|
|
|
| NEWSROOM: This Week |
|
July 24, 2008
-
PAH More Severe In Carriers Of BMPR2 Mutation
(Medscape/Reuters ) --
Among patients with pulmonary arterial hypertension (PAH), those with germline mutations in the gene encoding bone morphogenetic protein receptor 2 (BMPR2) present at an earlier age and with more severe hemodynamic compromise, according to findings from a French study.
July 23, 2008
-
Sleep Apnea May Spur Night Heart Attacks
(WebMD ) --
Obstructive sleep apnea "may be a trigger" for heart attacks, write the researchers, who included the Mayo Clinic's Fatima Kuniyoshi, PhD. Kuniyoshi's team calls for further studies to see if obstructive sleep apnea treatment reduces heart attack risk, especially at night.
-
Second Fen-Phen Lawyer Seeks Release From Jail
(Lexington Herald-Leader ) --
Shirley Cunningham Jr. wants a federal judge to release him from the Boone County jail, pending a second trial on criminal charges that he defrauded former fen-phen clients.
July 21, 2008
-
Transplant Games Celebrated Success Of Organ Donations
(NephrOnline ) --
Georgene suffered from pulmonary hypertension, and endured an eleven-month hospital stay, waiting for and recovering from heart/double lung transplant nearly 10 years ago. Immunosuppression led to kidney failure and another transplant two years ago.
-
Organ Donation Finding Place Online In Texas, Other States
(The Dallas Morning News ) --
Mr. Berwick spent five years on the waiting list for heart and lung transplants. He now manages his pulmonary hypertension with medication, but he knows he could be back on those lists if his condition deteriorates.
-
Ikaria's INOflo (Nitric Oxide) For Inhalation Approved In Japan
(PRNewswire ) --
Ikaria Holdings, Inc., through its subsidiary INO Therapeutics LLC, announced today that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved INOflo(R) (nitric oxide) for inhalation for improvement of hypoxic respiratory failure (HRF) with concurrent pulmonary hypertension in neonates.
Link to the Archives Page
|
|
 |
|
|
